• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion

    6/18/25 8:30:00 AM ET
    $INBS
    Medical/Dental Instruments
    Health Care
    Get the next $INBS alert in real time by email

    NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that Managed Waste Service ("MWS"), a leading Australian waste management provider, plans to implement INBS' Intelligent Fingerprinting Drug Screening System across its New South Wales operations, including its land clearing and green waste processing sites.

    The decision marks MWS's first move into in-house drug testing across multiple locations, with more than 20 sites simultaneously engaged in remote testing operations. MWS plans to conduct pre-employment, random, and for-cause testing on-site, giving operational teams complete control over safety processes without the disruption associated with traditional outsourced models.

    "In our industry, efficiency and safety go hand-in-hand," commented Con Constantinou, Partner at Managed Waste Service. "We operate across more than 20 sites at any given time and must ensure that every team member is fit for work daily. INBS' on-site testing solution provides the visibility and speed we need to stay compliant and keep teams safe."

    The Intelligent Fingerprinting Drug Screening System offers a quick, non-invasive method to screen for recent drug use through fingerprint sweat analysis, delivering results in under ten minutes. INBS' technology enables MWS to implement a scalable, portable solution that aligns with the nature of their fieldwork, whether testing at a remote clearing site or managing compliance across several waste facilities simultaneously.

    "For companies like MWS, testing needs to happen where the work happens," said Doug Heath, Vice President of Global Sales at Intelligent Bio Solutions. "This is about removing complexity. Our system gives teams across a broad range of sectors the tools to act quickly and benefit from rapid, non-invasive testing that's easy to administer, requires no specialized training, and supports safer, more efficient workplaces."

    This implementation reflects INBS' continued expansion into safety-critical industries, with environmental services now joining a growing portfolio of sectors adopting sweat-based drug testing. As industries seek more innovative, practical, and scalable ways to manage safety and risk, fingerprint drug testing is gaining increasing recognition as the most effective, dignified, and fastest option. INBS is transforming drug testing, with more than 450 organizations across 24 countries using its technology to streamline and simplify workplace testing.

    About Managed Waste Service

    Managed Waste Service is a waste and recycling company committed to landfill reduction and advancing a circular economy. It provides solutions across general waste, recycling, liquid waste, coffee grind collection, and green waste. Its zero-waste services support industries including hospitality, events, floristry, and landscaping, diverting materials like lawn clippings and coffee grinds from landfill. With a flexible fleet of hook-lift, front-loader, rear-loader, and skip trucks, the company services sites of all sizes. It also tracks waste data to support customer sustainability goals. Managed Waste Service delivers practical, sustainable business, environment, and budget outcomes. Through its innovative approach, Managed Waste Service delivers sustainable outcomes that align with business needs, environmental goals, and long-term cost efficiency.

    For more information, visit: https://mwsg.com.au/

    About Intelligent Bio Solutions Inc.

    Intelligent Bio Solutions Inc. (NASDAQ:INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company's current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, mining, drug treatment organizations, and coroners.

    For more information, visit: https://www.ibs.inc

    Forward-Looking Statements: 

    Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, Intelligent Bio Solutions Inc.'s ability to successfully develop and commercialize its drug and diagnostic tests, realize commercial benefit from its partnerships and collaborations, and secure regulatory approvals, among others. Although Intelligent Bio Solutions Inc. believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Intelligent Bio Solutions Inc. has attempted to identify forward-looking statements by terminology, including "believes," "estimates," "anticipates," "expects," "plans," "projects," "intends," "potential," "may," "could," "might," "will," "should," "approximately" or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, included in Intelligent Bio Solutions' public filings filed with the Securities and Exchange Commission. Any forward-looking statements contained in this release speak only as of its date. Intelligent Bio Solutions undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.

    Company Contact:

    Intelligent Bio Solutions Inc.

    [email protected]

    LinkedIn | Twitter 

    Investor & Media Contact:

    Valter Pinto, Managing Director

    KCSA Strategic Communications

    PH: (212) 896-1254

    [email protected]



    Primary Logo

    Get the next $INBS alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $INBS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $INBS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia

      NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, non-invasive drug screening solutions, today announced the success of its ongoing partnership with Spjotgard, an established distributor serving the Scandinavian market. The collaboration is accelerating the adoption of the Intelligent Fingerprinting Drug Screening System across Sweden, Norway, and Denmark, with a growing interest in Finland. Spjotgard, founded in 2021 by a team with deep pharmaceutical expertise, has rapidly developed a strong regional footprint, positioning INBS' fingerprint drug testing technology as it

      6/25/25 8:30:00 AM ET
      $INBS
      Medical/Dental Instruments
      Health Care
    • Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion

      NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that Managed Waste Service ("MWS"), a leading Australian waste management provider, plans to implement INBS' Intelligent Fingerprinting Drug Screening System across its New South Wales operations, including its land clearing and green waste processing sites. The decision marks MWS's first move into in-house drug testing across multiple locations, with more than 20 sites simultaneously engaged in remote testing operations. MWS plans to conduct pre-employment, random, an

      6/18/25 8:30:00 AM ET
      $INBS
      Medical/Dental Instruments
      Health Care
    • IBN Announces Latest Episode of The BioMedWire Podcast Featuring Harry Simeonidis, President and CEO of Intelligent Bio Solutions Inc.

      AUSTIN, Texas, June 17, 2025 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The BioMedWire Podcast delivers dynamic interviews with industry experts at the forefront of pharmaceutical and biotech advancement. The latest episode features Harry Simeonidis, CEO of Intelligent Bio Solutions Inc. (NASDAQ:INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions. D

      6/17/25 8:00:00 AM ET
      $INBS
      Medical/Dental Instruments
      Health Care

    $INBS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Chief Financial Officer Sakiris Spiro Kevin was granted 34,500 shares, increasing direct ownership by 10,952% to 34,815 units (SEC Form 4)

      4/A - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Issuer)

      3/31/25 4:15:27 PM ET
      $INBS
      Medical/Dental Instruments
      Health Care
    • Chief Executive Officer Simeonidis Harry was granted 40,000 shares, increasing direct ownership by 9,804% to 40,408 units (SEC Form 4)

      4 - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Issuer)

      9/27/24 5:00:16 PM ET
      $INBS
      Medical/Dental Instruments
      Health Care
    • Chief Financial Officer Sakiris Spiro Kevin was granted 34,500 shares, increasing direct ownership by 10,952% to 34,815 units (SEC Form 4)

      4 - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Issuer)

      9/27/24 5:00:15 PM ET
      $INBS
      Medical/Dental Instruments
      Health Care

    $INBS
    SEC Filings

    See more
    • Intelligent Bio Solutions Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Filer)

      7/3/25 4:15:34 PM ET
      $INBS
      Medical/Dental Instruments
      Health Care
    • SEC Form S-8 filed by Intelligent Bio Solutions Inc.

      S-8 - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Filer)

      5/30/25 5:26:11 PM ET
      $INBS
      Medical/Dental Instruments
      Health Care
    • Intelligent Bio Solutions Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Filer)

      5/16/25 8:00:18 AM ET
      $INBS
      Medical/Dental Instruments
      Health Care

    $INBS
    Financials

    Live finance-specific insights

    See more
    • Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements

      20% sequential quarterly revenue growth and 91% year-over-year quarterly gross profit growth Continued momentum from recurring higher-margin cartridge sales now reaching 58% of total sales for the nine months ended March 31, 2025  35 new accounts and international growth during Q3 bring total active accounts to over 450 NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its financial results for the fiscal third quarter and nine months ended March 31, 2025, and provided a business update.   The Company delivered a st

      5/13/25 8:30:00 AM ET
      $INBS
      Medical/Dental Instruments
      Health Care
    • Intelligent Bio Solutions Announces Fiscal Q2 2025 Financial Results and Key Operational Achievements

      Gross profit increase of 32.6% and 11-point gross profit margin increase driven by higher-margin cartridge sales Submitted FDA 510(k) and remain on track for planned expansion into multi-billion dollar U.S. market in 2025 Added strategic partnerships, increasing visibility across the Asia-Pacific Region and the U.S. Secured 19 accounts during quarter, adding to 400+ active customer accounts in 19 countries NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its financial results for the fiscal second quarter and six

      2/13/25 8:30:00 AM ET
      $INBS
      Medical/Dental Instruments
      Health Care
    • Intelligent Bio Solutions Inc. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results and Operational Highlights

      - Fourth-quarter revenue of $0.73 million, up 64% year-over-year – - Full-year revenue of $3.11 million, up 148% year-over-year – - As of June 30, 2024, the Company had $6.30 million in cash - NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, announced its financial results for the fiscal fourth quarter and full-year ended June 30, 2024, and provided a business update. Fiscal fourth quarter revenue totalled $0.73 million, an increase of 64% compared to the same period the prior year, and full-year revenue totalled $3.11 million,

      9/19/24 8:30:00 AM ET
      $INBS
      Medical/Dental Instruments
      Health Care

    $INBS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Intelligent Bio Solutions Inc.

      SC 13G/A - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Subject)

      11/14/24 7:16:17 PM ET
      $INBS
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by Intelligent Bio Solutions Inc.

      SC 13G - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Subject)

      11/14/24 4:31:30 PM ET
      $INBS
      Medical/Dental Instruments
      Health Care